• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Mitochondrial Transfer Can Help or Harm Hearts Depending on Cellular Context

by
November 19, 2026
in Health
Reading Time: 2 mins read
0
Mitochondrial Transfer Can Help or Harm Hearts Depending on Cellular Context

Mitochondrial Transfer Can Help or Harm Hearts Depending on Cellular Context

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Intercellular mitochondrial transfer produces divergent, context-dependent outcomes in cardiovascular disease, operating either to restore bioenergetics or propagate tissue injury depending on physiological conditions, according to a scientific review published in Molecular Medicine by researchers Yuhong Tang and Feng Huang. The analysis evaluates how mitochondrial homeostasis reaches beyond cell-autonomous quality control systems, emphasizing that mitochondrial movement between cells cannot be characterized as uniformly beneficial or uniformly harmful.

In certain cellular contexts, transferred mitochondria can rescue cellular bioenergetics and support active cardiovascular tissue repair. However, when damaged mitochondrial material is transferred instead, the process can propagate oxidative stress, trigger sustained inflammatory signaling, and regulate pathways of programmed cell death. This fundamental duality has historically limited therapeutic interpretation across cardiac research.

To resolve these conflicting outcomes, the review examines how the exact identity and functional state of transferred mitochondrial material interact with the donor cell state, the physical transfer route, recipient cell metabolism, local inflammatory context, and intracellular processing pathways. The authors explicitly differentiate endogenous intercellular mitochondrial transfer, which occurs naturally between cells, from mitochondrial transplantation, which involves the deliberate therapeutic administration of isolated mitochondrial preparations into diseased tissues.

The researchers assess these dynamics across multiple major cardiovascular settings, comparing the physical source and form of transferred material, administration routes, recipient responses, and the overall strength of evidence for clinical benefit versus harm. These evaluated conditions include acute ischemia and reperfusion injury, cardiomyopathy, heart failure, vascular dysfunction, pulmonary hypertension, critical illness related myocardial injury, and donor heart preservation during transplantation procedures.

According to the review, therapeutic benefit is most plausible when transferred mitochondria possess preserved respiratory function, encounter salvageable recipient cells within a permissive metabolic window, and operate where recipient intracellular quality control systems remain functional.

Conversely, the delivery of oxidatively damaged mitochondria, the presence of metabolic mismatch, or defective recipient clearance machinery can rapidly convert mitochondrial transfer into an inflammatory and cytotoxic burden. Because conventional approaches have frequently treated mitochondrial movement as a uniform organelle-replacement strategy, the authors advocate reframing mitochondrial transfer as a multi-node, pharmacologically tractable biological network where distinct stages of transfer can be individually modulated or therapeutically targeted.

Several translational opportunities emerge from this network perspective, including quality-controlled mitochondrial transplantation protocols, the application of mitochondria-enriched extracellular vesicles, and targeted or biomaterial-assisted delivery systems.

Moving forward, the authors conclude that future translational development must systematically couple rigorous product identity, purity, potency, and safety evaluations with mechanism-based patient stratification, recipient-cell tracing techniques, and clinically relevant long-term cardiovascular endpoints. Establishing this context-guided framework is essential for designing precise mitochondria-based therapeutics and clearly defining when mitochondrial supplementation should be actively promoted, redirected, or avoided.

Subject of Research: Context-dependent mitochondrial transfer and therapeutic translation in cardiovascular disease

Article Title: Context-dependent mitochondrial transfer in cardiovascular disease: mechanisms and therapeutic translation

Article References: Tang, Y., & Huang, F. (2026). Context-dependent mitochondrial transfer in cardiovascular disease: mechanisms and therapeutic translation. Molecular Medicine. https://doi.org/10.1186/s10020-026-01669-0

Image Credits: AI Generated

DOI: 10.1186/s10020-026-01669-0

Keywords: mitochondrial transfer, mitochondrial transplantation, cardiovascular disease, mitochondrial dysfunction, ischemia reperfusion injury, cardiomyopathy, heart failure, pulmonary hypertension, vascular dysfunction, donor heart preservation, cellular bioenergetics, extracellular vesicles, macrophage clearance, oxidative stress, organelle quality control, targeted delivery

News Source: Ophelia Keating. (November 19, 2026). Mitochondrial Transfer Can Help or Harm Hearts Depending on Cellular Context. Scienmag.

Tags: cardiomyopathyCardiovascular diseasecellular bioenergeticsdonor heart preservationextracellular vesiclesheart failureIschemia-reperfusion injurymacrophage clearanceMitochondrial dysfunctionMitochondrial transfermitochondrial transplantationorganelle quality controloxidative stresspulmonary hypertensionTargeted Deliveryvascular dysfunction
Share12Tweet7Share2ShareShareShare1

Related Posts

Non-Operative Grade III MCL Tear Treatment Matches Grade II Long-Term Outcomes

Non-Operative Grade III MCL Tear Treatment Matches Grade II Long-Term Outcomes

November 19, 2026
West African Forensic Psychiatry Systems Face Structural Gaps Despite Emerging Legal Reforms

West African Forensic Psychiatry Systems Face Structural Gaps Despite Emerging Legal Reforms

November 19, 2026

Cerebrospinal Fluid Proteomics Distinguishes Stages of Alzheimer’s Disease Continuum

November 19, 2026

Postpandemic Social Contacts in Japan and South Korea Remain Below Historical Baselines

November 19, 2026

POPULAR NEWS

  • Study Finds Autism Diagnosed in Twenty-Eight Percent of Children With Neurofibromatosis Type 1

    Study Finds Autism Diagnosed in Twenty-Eight Percent of Children With Neurofibromatosis Type 1

    29 shares
    Share 12 Tweet 7
  • Esketamine with Pulsed Radiofrequency Alleviates Neuropathic Pain in Herpes Zoster Patients

    29 shares
    Share 12 Tweet 7
  • Fences Restrict Movement and Alter Space Use in Endangered Masai Giraffes

    29 shares
    Share 12 Tweet 7
  • Stem Cell Delivery Repairs Post-Stroke Endoplasmic Reticulum Dynamics in Rat Model

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Non-Operative Grade III MCL Tear Treatment Matches Grade II Long-Term Outcomes

Engineered Microstructural Heterogeneity Improves Defect Tolerance in Laser Powder Bed Fusion

West African Forensic Psychiatry Systems Face Structural Gaps Despite Emerging Legal Reforms

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.